Dual Eligibility, Chronic Disease Burden, and Clinically Recognized Disease Progression Among Medicare Advantage Beneficiaries

Chronic disease burden is a major driver of morbidity, mortality, and health care expenditures. Dual-eligible Medicare beneficiaries have a greater burden of chronic disease and higher health care utilization than Medicare-only beneficiaries. Factors associated with clinically recognized disease progression are not well understood. To address this gap, a retrospective cohort study of 368 Medicare Advantage beneficiaries aged 65 years and older receiving annual care in two primary care practices from 2018 through 2022 was conducted. Disease progression was determined from detailed electronic medical record review and was based on clinical assessments documented by treating providers. Disease progression occurred more frequently among dual-eligible than non-dual-eligible beneficiaries (45.3% vs. 33.3%). Dual-eligible beneficiaries also had a greater baseline chronic disease burden (mean 4.42 vs. 3.37 chronic diseases). The percentage of patients that progressed increased with increasing chronic disease burden, and each additional chronic disease was associated with higher odds of progression (adjusted odds ratio 1.58, 95% confidence interval [1.33-1.88]). After adjustment for chronic disease burden and demographic factors, dual-eligible status was not independently associated with disease progression. Beneficiaries with comparable chronic disease burden had similar probabilities of progression regardless of dual-eligible status. These findings show that the greater likelihood of disease progression observed among dual-eligible Medicare Advantage beneficiaries that are continuously followed in a clinical practice is largely explained by chronic disease burden. These findings reinforce the role of continuous care for dual-eligible patients and the importance of prevention and control of chronic disease management.

Authors

Institutions

Publication Details

Journal
Population Health Management
Published
2026-11-18
DOI
https://doi.org/10.1177/19427891261508984
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual Eligibility, Chronic Disease Burden, and Clinically Recognized Disease Progression Among Medicare Advantage Beneficiaries

Michael A. Kolber
Population Health Management
Chronic Disease Management Strategies
article

Dual Eligibility, Chronic Disease Burden, and Clinically Recognized Disease Progression Among Medicare Advantage Beneficiaries

Michael A. Kolber
article en

Abstract

Chronic disease burden is a major driver of morbidity, mortality, and health care expenditures. Dual-eligible Medicare beneficiaries have a greater burden of chronic disease and higher health care utilization than Medicare-only beneficiaries. Factors associated with clinically recognized disease progression are not well understood. To address this gap, a retrospective cohort study of 368 Medicare Advantage beneficiaries aged 65 years and older receiving annual care in two primary care practices from 2018 through 2022 was conducted. Disease progression was determined from detailed electronic medical record review and was based on clinical assessments documented by treating providers. Disease progression occurred more frequently among dual-eligible than non-dual-eligible beneficiaries (45.3% vs. 33.3%). Dual-eligible beneficiaries also had a greater baseline chronic disease burden (mean 4.42 vs. 3.37 chronic diseases). The percentage of patients that progressed increased with increasing chronic disease burden, and each additional chronic disease was associated with higher odds of progression (adjusted odds ratio 1.58, 95% confidence interval [1.33-1.88]). After adjustment for chronic disease burden and demographic factors, dual-eligible status was not independently associated with disease progression. Beneficiaries with comparable chronic disease burden had similar probabilities of progression regardless of dual-eligible status. These findings show that the greater likelihood of disease progression observed among dual-eligible Medicare Advantage beneficiaries that are continuously followed in a clinical practice is largely explained by chronic disease burden. These findings reinforce the role of continuous care for dual-eligible patients and the importance of prevention and control of chronic disease management.

Population Health Management
University of Miami (US)
Chronic Disease Management Strategies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon